ArticleOncoimmunology2022

Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression.

Donghwan Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.